B. Christopher Kim

About

Chris is a seasoned life sciences executive with over two decades of cross-sector leadership across biotech, venture capital, and big pharma, with a proven track record in corporate development, dealmaking and global partnering that has consistently delivered impactful outcomes. He served as EVP of corporate development at Bridge Biotherapeutics where he played a central role in negotiating an out-licensing deal valued at over $1B with a global big pharma company. Previously, he co-founded the Korea-Seoul Life Science Fund, the first US-Korea cross-border biotech VC fund and the largest dedicated biot

Source (opens in a new tab)